Rare diseases
Investigational molecules
Locations
Phase 1/2 Study of Oral TRI-611 in Adults With Advanced ALK‑Positive Non‑Small Cell Lung Cancer
FranceColchicine for Reducing Dependency and Vascular Events in Patients After Acute Intracerebral Hemorrhage
BelgiumCapecitabine drug combination in perioperative treatment for patients with gastric and esophageal cancer
The NetherlandsA Phase 3 Study of Delgocitinib Cream to Evaluate Efficacy and Safety in Adult Women with Lichen Sclerosus
FranceEvaluation of belantamab mafodotin plus drug combination in adult patients with newly diagnosed light chain amyloidosis
GreeceSafety, Dose‑Finding and Feasibility Study of CD30/CEA CART in Patients with Liver Metastases from CEA‑Positive Colorectal Cancer
GermanySafety and Tolerability of PTI5803 in Patients Aged 14 Years and Older With Drug‑Resistant Seizures Due to Focal Cortical Dysplasia
FranceStudy of Doxycycline Bone and Joint Penetration in Patients Undergoing Total Hip Arthroplasty for Hip Osteoarthritis
FrancePhase II study of autologous enriched T‑cell therapy expressing CD19 and CD22 CARs in Philadelphia‑negative B‑precursor ALL patients with measurable residual disease
GermanyRopivacaine hydrochloride versus electrolytes for pain relief in women undergoing second‑trimester medical abortion after 13 weeks
SwedenStudy of melpida with drug combination in patients with Hereditary Spastic Paraplegia Type 50 (SPG50)
SpainEfficacy and Safety of Transmucosal Midazolam for Proportional Palliative Sedation in Children with Refractory Symptoms
FranceTell us about your condition – we search every trial in Europe and connect you with the right site.
